These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18034590)

  • 21. The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma.
    Lutz MP; Zalcberg JR; Ducreux M; Adenis A; Allum W; Aust D; Carneiro F; Grabsch HI; Laurent-Puig P; Lordick F; Möhler M; Mönig S; Obermannova R; Piessen G; Riddell A; Röcken C; Roviello F; Schneider PM; Seewald S; Smyth E; van Cutsem E; Verheij M; Wagner AD; Otto F
    Eur J Cancer; 2019 May; 112():1-8. PubMed ID: 30878666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant therapy of esophageal cancer.
    Ilson DH; Bains M; Ginsberg RJ; Kelsen DP
    Surg Oncol Clin N Am; 1997 Oct; 6(4):723-40. PubMed ID: 9309090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peri-operative therapy for operable gastroesophageal adenocarcinoma: past, present and future.
    Aggelis V; Cunningham D; Lordick F; Smyth EC
    Ann Oncol; 2018 Jun; 29(6):1377-1385. PubMed ID: 29771279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and treatment of gastric cancer.
    Hendlisz A; Bleiberg H
    Drugs; 1995 May; 49(5):711-20. PubMed ID: 7601012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
    Haisley KR; Hart KD; Nabavizadeh N; Bensch KG; Vaccaro GM; Thomas CR; Schipper PH; Hunter JG; Dolan JP
    Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
    Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M;
    Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stage for stage comparison of recurrence patterns after definitive chemoradiotherapy or surgery for oesophageal carcinoma.
    Reid TD; Davies IL; Mason J; Roberts SA; Crosby TD; Lewis WG
    Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):617-24. PubMed ID: 22386923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
    Chen J; Yin W; Yao H; Gu W
    Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300.
    Bang YJ; Ruiz EY; Van Cutsem E; Lee KW; Wyrwicz L; Schenker M; Alsina M; Ryu MH; Chung HC; Evesque L; Al-Batran SE; Park SH; Lichinitser M; Boku N; Moehler MH; Hong J; Xiong H; Hallwachs R; Conti I; Taieb J
    Ann Oncol; 2018 Oct; 29(10):2052-2060. PubMed ID: 30052729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination 5-fluoruracil/cisplatinum versus 5-fluoruracil/leucovorin adjuvant chemotherapy efficacy for R0 gastric resection in locally invasive gastric cancer.
    Yamada S; Ritchim P; Charkrabandhu T; Jongraksat W
    J Med Assoc Thai; 2012 Dec; 95(12):1517-23. PubMed ID: 23390781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Definitive chemoradiotherapy for oesophageal cancer -- a promising start on an exciting journey.
    Rackley T; Leong T; Foo M; Crosby T
    Clin Oncol (R Coll Radiol); 2014 Sep; 26(9):533-40. PubMed ID: 24984577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative chemotherapy with FOLFOX in resectable gastroesophageal adenocarcinoma in real life practice: An AGEO multicenter retrospective study.
    Mary F; Zaanan A; Boige V; Artru P; Samalin E; Coriat R; Bachet JB; Boubaya M; Benallaoua M; Tougeron D; Afchain P; Locher C; Baumgaertner I; Lecaille C; des Guetz G; Aparicio T;
    Dig Liver Dis; 2016 Dec; 48(12):1498-1502. PubMed ID: 27623185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CROSS and beyond: a clinical perspective on the results of the randomized ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study.
    van der Woude SO; Hulshof MC; van Laarhoven HW
    Chin Clin Oncol; 2016 Feb; 5(1):13. PubMed ID: 26932437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approaches.
    Davidson M; Chau I
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):327-338. PubMed ID: 29431018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimodality treatment for localized gastro-oesophageal cancer.
    Okines AF; Cunningham D
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii286-93. PubMed ID: 20943630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current options in the management of gastrointestinal cancer.
    Middleton G; Cunningham D
    Ann Oncol; 1995; 6 Suppl 1():17-25; discussion 25-6. PubMed ID: 8695539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Radiotherapy in cancers of the oesophagus, the gastric cardia and the stomach].
    Créhange G; Huguet F; Quero L; N'Guyen TV; Mirabel X; Lacornerie T
    Cancer Radiother; 2016 Sep; 20 Suppl():S161-8. PubMed ID: 27523409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma.
    Li SH; Rau KM; Lu HI; Wang YM; Tien WY; Liang JL; Lin WC
    Eur J Cardiothorac Surg; 2012 Dec; 42(6):958-64. PubMed ID: 22466694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in the Management of Gastric and Gastroesophageal Cancers.
    Kamran SC; Hong TS; Wo JY
    Curr Oncol Rep; 2016 Feb; 18(2):13. PubMed ID: 26769118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Landmark Series: Multimodal Therapy for Esophageal Cancer.
    Demarest CT; Chang AC
    Ann Surg Oncol; 2021 Jun; 28(6):3375-3382. PubMed ID: 33629251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.